Close Menu

NEW YORK (GenomeWeb) – Invitae reported after the close of the market on Tuesday a 160 percent year-over-year increase in second quarter revenues driven by 139 percent growth in testing volume.

For the three months ended June 30, the company posted $37.3 million in revenue, up 160 percent from $14.3 million in Q2 of 2017, and beating the consensus Wall Street estimate of $31.7 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The chief executive of the National Health Service in England is to call for tumor-agnostic drugs to be "fast-tracked," according to the Times.

Researchers in Australia are sequencing the Wollemi pine tree to try to protect it from extinction, Australia's ABC News reports.

Computerworld ranks Illumina as one of the top midsize organizations to work at in IT.

In Genome Research this week: links between biological aging and mutations affecting epigenetic regulators; long-read sequencing-based strategy to map chromatin accessibility; and more.